4CPS-151 Optimisation programme of biological therapies in rheumatoid arthritis: results of create registry after 3 years

BACKGROUND: Dose optimisation (dose reduction or dose spacing) is a therapeutic strategy applied in patients with rheumatoid arthritis (RA) who have managed to maintain clinical remission. This strategy reduces the frequency of adverse effects and promotes cost savings. PURPOSE: Evaluate effectivene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Autores principales: Ruiz, S de la Fuente, Ugalde, P Font, Aranzana, M Cárdenas, Villegas, MC Castro, Gómez, M Romero, Castro, R Ortega, Guitiérrez, J Calvo, Vílchez, D Ruiz, Estévez, E Colllantes
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2018
Materias:
Section 4: Clinical pharmacy services
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.242
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares